Page last updated: 2024-09-04

naproxen and methylprednisolone

naproxen has been researched along with methylprednisolone in 21 studies

Compound Research Comparison

Studies
(naproxen)
Trials
(naproxen)
Recent Studies (post-2010)
(naproxen)
Studies
(methylprednisolone)
Trials
(methylprednisolone)
Recent Studies (post-2010) (methylprednisolone)
4,5511,0571,42920,2472,6025,317

Protein Interaction Comparison

ProteinTaxonomynaproxen (IC50)methylprednisolone (IC50)
Glucocorticoid receptorHomo sapiens (human)0.011
Glycine receptor subunit alpha-1Rattus norvegicus (Norway rat)0.011
Glycine receptor subunit betaRattus norvegicus (Norway rat)0.011
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)0.011
Glycine receptor subunit alpha-3Rattus norvegicus (Norway rat)0.011

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19902 (9.52)18.7374
1990's4 (19.05)18.2507
2000's4 (19.05)29.6817
2010's11 (52.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Lane, NE; Schurman, DJ; Smith, RL; Williams, RJ1
Bello López, JL; Fonseca, E; Manso, F1
Kumar, KL; Lucas, LM; McAfee, JH; Romney, DM; Smith, DL1
Chaudhuri, G; Hayden, B; Soderberg, R; Zarem, H1
Asselin, I; Célestin, F; Entman, M; Goulet, M; Guérette, B; Huard, C; Roy, B; Roy, R; Skuk, D; Tardif, F; Tremblay, JP1
Croft, P; Hay, EM; Hosie, G; Lewis, M; Paterson, SM1
Chu, SC; Hsieh, YS; Li, TJ; Lu, KH; Lue, KH; Yang, SF1
Ertugrul, BM; Gencer, P; Ozturk, B; Sakarya, S; Saylak Ersoy, OM1
De Nisco, A; De Rosa, G; Piastra, M; Rigante, D; Valentini, P1

Reviews

1 review(s) available for naproxen and methylprednisolone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for naproxen and methylprednisolone

ArticleYear
Treatment of nonseptic olecranon bursitis. A controlled, blinded prospective trial.
    Archives of internal medicine, 1989, Volume: 149, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bursitis; Double-Blind Method; Drug Therapy, Combination; Elbow Joint; Humans; Injections; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Naproxen; Prospective Studies; Randomized Controlled Trials as Topic; Ulna

1989
Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care.
    BMJ (Clinical research ed.), 1999, Oct-09, Volume: 319, Issue:7215

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Methylprednisolone; Middle Aged; Naproxen; Tennis Elbow; Treatment Outcome

1999

Other Studies

18 other study(ies) available for naproxen and methylprednisolone

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Inhibition of interleukin 1 induced chondrocyte protease activity by a corticosteroid and a nonsteroidal antiinflammatory drug.
    The Journal of rheumatology, 1992, Volume: 19, Issue:1

    Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Caseins; Collagen; Endopeptidases; Interleukin-1; Methylprednisolone; Naproxen; Prostaglandins E; Protease Inhibitors

1992
Sweet's syndrome during the chronic phase of chronic myeloid leukaemia.
    Acta haematologica, 1990, Volume: 84, Issue:4

    Topics: Drug Therapy, Combination; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Leukocytosis; Male; Methylprednisolone; Middle Aged; Naproxen; Neutrophils; Skin Diseases; Syndrome

1990
Salvage of ischemic rabbit ear by BW-755C and steroids, but not by indomethacin.
    Prostaglandins, 1987, Volume: 33, Issue:1

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents; Ear; Indomethacin; Ischemia; Methylprednisolone; Naproxen; Necrosis; Pyrazoles; Rabbits

1987
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
    Journal of immunology (Baltimore, Md. : 1950), 1997, Sep-01, Volume: 159, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; beta-Galactosidase; Biomarkers; Cell Adhesion; Cell Death; Cell Line, Transformed; Fluoresceins; Genes, Reporter; Graft Rejection; Immunosuppressive Agents; Inflammation; Interleukin-1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Naproxen; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; Piroxicam; Radiation Chimera; Stem Cell Transplantation; Tacrolimus; Whole-Body Irradiation; Zymosan

1997
Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis.
    Clinica chimica acta; international journal of clinical chemistry, 2008, Volume: 387, Issue:1-2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Gelatinases; Humans; Meloxicam; Methylprednisolone; Naproxen; Osteoarthritis; Thiazines; Thiazoles; Urokinase-Type Plasminogen Activator

2008
Adult-onset Still's disease in an 83-year-old.
    Journal of the American Geriatrics Society, 2012, Volume: 60, Issue:1

    Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Diagnosis, Differential; Female; Follow-Up Studies; Glucocorticoids; Humans; Methylprednisolone; Naproxen; Still's Disease, Adult-Onset; Tomography, X-Ray Computed

2012
Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis.
    Reumatismo, 2016, Sep-09, Volume: 68, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Diagnosis, Differential; Humans; Male; Methylprednisolone; Naproxen; Pericarditis; Pulse Therapy, Drug; Thoracentesis; Treatment Outcome

2016